RIZATRIPTAN TW rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Mevcut itibaren:

Arrotex Pharmaceuticals Pty Ltd

INN (International Adı):

rizatriptan benzoate

Farmasötik formu:

Tablet, orally disintegrating

Kompozisyon:

Excipient Ingredients: mannitol; crospovidone; sodium stearylfumarate; ethylcellulose; colloidal anhydrous silica; silicon dioxide; hypromellose; acesulfame potassium; Flavour

Uygulama yolu:

Sublingual

Paketteki üniteler:

3, 2, 6

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

for acute treatment of migraine attacks with or without aura.

Ürün özeti:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2015-03-20